Boehringer Ingelheim contest seeks COPD songs

Share this article:
Boehringer Ingelheim contest seeks COPD songs
Boehringer Ingelheim contest seeks COPD songs
Boehringer Ingelheim is partnering with the Country Music Association for a Tune Up For COPD Songwriting Competition featuring country music stars Billy Ray Cyrus and Patty Loveless.

The contest is soliciting “songs with a motivational message that encourages people to be proactive in taking control of their lives and be healthy,” and the winner will perform it live at the CMA Music Festival in Nashville in June. Contestants can upload their videos and lyrics sheets to tuneup4copd.cmaworld.com, and a “fan favorite” will be determined by the highest number of online votes and showcased online. The overall winner will be selected by a panel of judges including Cyrus, Loveless, industry experts and members of participating organizations including the American Association for Respiratory Care, Country Music Association, COPD Alliance, COPD Foundation, NASCAR and US COPD Coalition.

Cyrus is the newest celebrity addition to Boehringer Ingelheim's COPD awareness efforts, which have also featured Jim Belushi, driver Danica Patrick and football star Michael Strahan. Cyrus's grandfather, a pastor, suffered from COPD. Loveless last year penned the song Drive for the company's Drive4COPD campaign, honoring her sister Dottie, who died of COPD at age 48.

COPD, which includes chronic bronchitis and emphysema, affects an estimated 24 million Americans. Boehringer Ingelheim's COPD products include Spiriva, Combivent, Atrovent and Berodual/Bronchodual/Duovent.
Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...